InvestorsHub Logo
Followers 5
Posts 290
Boards Moderated 0
Alias Born 11/07/2014

Re: exwannabe post# 206761

Saturday, 01/05/2019 5:10:30 PM

Saturday, January 05, 2019 5:10:30 PM

Post# of 700347
Just go back and see what happened to Dendreon when they completed their first phase 3. There was a massive short position and when the advisory panel voted overwhelmingly to recommend approval the stock price got away from the shorts. Then what happened ? There was a massive and coordinated campaign including some scientists who were working on competing treatments who wrote letters to the FDA not to approve, AF doing his usual thing, etc. The FDA then sent Dendreon back to do another phase 3. That's what happened and that's how the shorts escaped. All fact, no fiction.

That's why I think LP will either partner or sell DCVax-L when topline is announced. There is no way that the shorts will allow the price to appreciate significantly from this level if NWBO is still independent and alone. They will do everything they can. They have shown that they can do this before. I know that LP knows this.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News